MCCANN JOE A. (Chief Executive Officer) reported 2 transactions at POINT BIOPHARMA GLOBAL INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/27/2023ACC: 0001104659-23-129775
DirectorOfficer· Chief Executive Officer
Since Jun 2021
-4.57M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
4.57M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.16K
Price / share
—
Trade value
—
% of position
New position
12/22/2023
2.16K→0.00
Common Stock
Indirect
Shares
−3.49M
Price / share
—
Trade value
—
% of position
New position
12/22/2023
3.49M→0.00
Total
Net shares
−3.50M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/22/2023 | U · U | −2.16K | — | — | New position | 2.16K | 0.00 |
| Common Stock Indirect | 12/22/2023 | U · U | −3.49M | — | — | New position | 3.49M | 0.00 |
| Total | −3.50M | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
381.80K shares
Shares
−381.80K
Strike price
8.13
Held after
0.00
Exercisable
—
12/27/2023
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
692.64K shares
Shares
−692.64K
Strike price
6.78
Held after
0.00
Exercisable
—
12/27/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock381.80K shares | 12/27/2023 | D · Disposition | −381.80K | 8.13 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock692.64K shares | 12/27/2023 | D · Disposition | −692.64K | 6.78 | — | 0.00 |